Emerging Therapeutic Strategies for Acne Vulgaris: Beyond Topical Treatments

Jennifer Linda^*
*Correspondence: Jennifer Linda, Department of Dermatology, University of Houston, 4300 Martin Luther King Blvd, Houston, TX 77204, USA, Email:

Keywords

Therapeutic • Vulgaris • Medications

Introduction

While topical treatments have been a mainstay in acne management, there exists a subset of patients who do not respond adequately to these therapies or experience intolerable side effects. Consequently, there is a growing recognition of the need for alternative therapeutic strategies that go beyond topical applications. This shift in perspective has led to the exploration of systemic medications, procedural interventions, and adjunctive therapies as viable options for individuals with persistent or severe acne vulgaris [1]. Despite the significant strides made in acne treatment, there remains a subset of patients for whom traditional topical therapies are insufficient or intolerable. This recognition has spurred the exploration of alternative therapeutic avenues, broadening the scope of acne management beyond conventional approaches. The quest for emerging therapeutic strategies for acne vulgaris reflects a commitment to addressing the diverse needs and challenges faced by patients, aiming for improved outcomes and enhanced quality of life. By delving into these novel treatment modalities, healthcare providers can better tailor acne management to individual patient profiles, fostering a more personalized and comprehensive approach to care [2].

Literature Review

Despite the efficacy of topical treatments such as retinoid, benzoyl peroxide, and antibiotics in many cases of acne vulgaris, a subset of patients fails to achieve satisfactory results or experiences adverse effects. In such instances, systemic medications, including oral antibiotics, hormonal therapies, and isotretinoin, may be considered as second-line treatment options. Furthermore, emerging research has highlighted the potential benefits of procedural interventions, such as laser therapy, photodynamic therapy, and chemical peels, in complementing conventional acne treatments and addressing specific acne subtypes or complications. Additionally, adjunctive therapies, including dietary modifications, probiotics, and botanical extracts, have garnered interest for their potential roles in modulating acne pathogenesis and enhancing treatment outcomes. By exploring these emerging therapeutic strategies, clinicians can expand their armamentarium for acne management, tailoring treatment approaches to individual patient needs and preferences while optimizing efficacy and minimizing adverse effects [3].

Discussion

Systemic medications represent a promising avenue for acne management, particularly in cases where topical treatments have proven ineffective or impractical. Oral antibiotics, such as tetracycline’s and macrolides, exert their antimicrobial effects by targeting Propionibacterium acnes, the bacterium implicated in acne pathogenesis. Hormonal therapies, including combined oral contraceptives and antiandrogens, offer benefits for patients with hormonal imbalances contributing to acne development, such as polycystic ovary syndrome. Isotretinoin, a potent oral retinoid, remains the gold standard for severe, recalcitrant acne, effectively targeting multiple pathogenic mechanisms, including sebum production, inflammation, and follicular hyperkeratinisation. Procedural interventions, such as laser therapy and photodynamic therapy, provide additional options for acne management by targeting specific acne lesions, reducing sebum production, and promoting skin rejuvenation. Adjunctive therapies, such as dietary modifications and botanical extracts, offer complementary approaches to acne treatment, addressing underlying factors such as inflammation, oxidative stress, and hormonal imbalance. By incorporating these emerging therapeutic strategies into clinical practice, healthcare providers can optimize treatment outcomes and improve the overall quality of care for patients with acne vulgaris.

Systemic medications offer a promising frontier in acne treatment, particularly for patients with moderate to severe forms of the condition or those unresponsive to topical agents. Oral antibiotics, such as doxycycline and minocycline, target the bacteria implicated in acne pathogenesis, while hormonal therapies provide relief for individuals with hormonal imbalances contributing to acne development. Isotretinoin, a potent oral retinoid, stands out as a highly effective option for severe, treatment-resistant acne, with its ability to address multiple pathogenic factors underlying the disease. Procedural interventions, including laser therapy and photodynamic therapy, offer targeted approaches for acne lesion reduction and skin rejuvenation. Adjunctive therapies, such as dietary modifications and botanical extracts, complement conventional treatments by addressing inflammatory pathways and supporting skin health. By integrating these emerging therapeutic strategies into clinical practice, healthcare providers can expand the treatment arsenal for acne vulgaris and improve outcomes for patients across the spectrum of disease severity [4-6].

Conclusion

The management of acne vulgaris is evolving, with emerging therapeutic strategies offering new avenues for personalized and comprehensive care. Beyond traditional topical treatments, systemic medications, procedural interventions, and adjunctive therapies present promising alternatives for patients with refractory or severe acne. By embracing these novel approaches, healthcare professionals can address the diverse needs and preferences of patients, improving treatment outcomes and enhancing overall satisfaction. Moving forward, continued research and clinical innovation are essential for advancing the field of acne therapeutics, unraveling the complexities of acne pathogenesis, and developing targeted interventions that address underlying disease mechanisms. With a comprehensive understanding of emerging therapeutic strategies, clinicians can navigate the evolving landscape of acne management, providing effective and tailored solutions for individuals affected by this common dermatological condition. The landscape of acne management is expanding, with emerging therapeutic strategies offering new hope for individuals burdened by this common dermatological condition. Beyond traditional topical treatments, systemic medications, procedural interventions, and adjunctive therapies present promising alternatives for patients resistant to conventional therapies or seeking more personalized approaches. By embracing these novel treatment modalities, healthcare providers can tailor acne management to individual patient needs and preferences, improving treatment efficacy and patient satisfaction. Moving forward, continued research and clinical innovation are essential for advancing the field of acne therapeutics, unraveling the complexities of acne pathogenesis, and developing targeted interventions that address underlying disease mechanisms. With a comprehensive understanding of emerging therapeutic strategies, clinicians can navigate the evolving landscape of acne management, providing effective and tailored solutions for individuals affected by this challenging dermatological condition.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Almutairi, Nawaf. "Atopic dermatitis and related disorders: Special types of presentation." Pediatr Dermatol (2019): 228-244.

Google Scholar, Crossref

2. David Lortscher, M., M. Shehla Admani, M. Nancy Satur and F. Lawrence. "Hormonal contraceptives and acne: A retrospective analysis of 2147 patients." J Drugs Dermatol 15 (2016): 670-674.

Google Scholar, Indexed at

3. Betarbet, Udayan and Travis W. Blalock. "Keloids: A review of etiology, prevention, and treatment." J Clin Aesthet Dermatol 13 (2020): 33.

Google Scholar, Indexed at

4. Dréno, Brigitte, Sophie Pécastaings, Stéphane Corvec and Stefano Veraldi, et al. "Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: A brief look at the latest updates." J Eur Acad Dermatol Venereol 32 (2018): 5-14.

Google Scholar, Crossref, Indexed at

5. Kircik, Leon H. "Advances in the understanding of the pathogenesis of inflammatory acne." J Drugs Dermatol 15 (2016): s7-10.

Google Scholar, Indexed at

6. Talianu, Marina-Theodora, Cristina-Elena Dinu-Pîrvu, Mihaela Violeta Ghica and Valentina Anuţa, et al. "Foray into concepts of design and evaluation of microemulsions as a modern approach for topical applications in acne pathology." Nanomater 10 (2020): 2292.

Google Scholar, Crossref, Indexed at